论文部分内容阅读
目的观察分析妊娠合并重型肝炎分娩前的临床治疗效果。方法将我院2008年2月-2012年12月妊娠合并重型肝炎的孕妇42例随机分为观察组和对照组各21例,对照组采取常规内科治疗,观察组在对照组基础上加用低分子肝素治疗,观察对比两组临床效果。结果两组孕妇在疗程结束后与开始前的ALP、ALT、AST的检测值对比皆有明显降低,观察组下降幅度更为显著(P<0.05),差异有统计学意义。结论对于妊娠合并重型肝炎患者,分娩前积极采取常规内科治疗联合低分子肝素加强治疗,对保障母婴安全有非常重要的临床意义。
Objective To observe the effect of clinical treatment before delivery in pregnancy complicated with severe hepatitis. Methods Forty-two pregnant women with severe hepatitis during pregnancy from February 2008 to December 2012 were randomly divided into observation group and control group, with 21 cases in each group. The control group received conventional medical treatment. The observation group was treated with low Molecular heparin treatment, observed and compared two groups of clinical results. Results After treatment, the pregnant women in both groups had significantly lower ALP, ALT and AST values after the end of treatment than those in the control group (P <0.05). The difference was statistically significant. Conclusion For pregnant patients with severe hepatitis, prenatal positive routine medical treatment combined with low molecular weight heparin to strengthen the treatment of maternal and child safety is very important clinical significance.